Person: KIZILTAN, HURİYE ŞENAY
39 results
Search Results
Now showing 1 - 10 of 39
Publication Metadata only huriye şenay kiziltan jst.go.jp alanından [PDF] Bone mineral density evaluation of patients with type 2 diabetes mellitus(2015-12-01) CAMLI, A; AYDIN, TEOMAN; TAŞPINAR, ÖZGÜR; KIZILTAN, HURİYE ŞENAY; ERIS, ALİ HİKMET; KESKİN, YAŞAR; HOCAOĞLU, İLKNUR TÜRK; POSUL, SEVDE; KEPEKÇİ, MÜGE; DENİZLİ, EBRU; GÜLER, MUSTAFA; AYDIN, TEOMAN; KIZILTAN, HURİYE ŞENAY; ERİŞ, ALİ HİKMETPublication Open Access Does ozone administration have a protective or therapeutic effect against radiotherapy-induced testicular injury?(2019-03-01) AYDOĞDU, İBRAHİM; İLBEY, YUSUF ÖZLEM; ÇOBAN, GANİME; EKİN, RAHMİ GÖKHAN; MİRAPOĞLU, SEMİH LÜTFİ; ÇAY, ALİ; KIZILTAN, HURİYE ŞENAY; EKİN, ZÜBEYDE YILDIRIM; SILAY, MESRUR SELÇUK; SEMERCİ, MEHMET BÜLENT; AYDOĞDU, İBRAHİM; ÇOBAN, GANİME; MİRAPOĞLU, SEMİH LÜTFİ; ÇAY, ALI; KIZILTAN, HURİYE ŞENAYObjective: We investigate the protective and therapeutic effects of ozone therapy (OT) in radiotherapy (RT)‑induced testicular damage. Methods: Thirty healthy adult male Wistar rats divided into five groups consisting of six animals each as follows: (1) Control (C), (2) RT, (3) OT, (4) OT + RT, and (5) RT + OT group. Histopathological findings, Johnsen scores, thiobarbituric acid‑reactive substances (TBARS), glutathione (GSH), superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPx) levels were evaluated. Results: RT caused a significant decrease in testicular weight and Johnsen score compared to the control group. In addition, TBARS level was significantly higher, whereas GSH, SOD, catalase, and GPx levels were significantly lower in the RT group when compared to the control group. Pre and postRT OT significantly increased GSH, SOD, catalase, and GPx levels and decreased TBARS level. Furthermore, testicular weight and Johnsen score were increased with OT. Conclusions: The present study showed that OT is protective and therapeutic in radiation‑induced testicular damage. OT may be beneficial to the patients who underwent RT.Publication Metadata only Cytotoxic, genotoxic and apoptotic activities of carvacrol from Thymus vulgaris on the human adenocarcinoma gastric cells(2015-08-01) GUNES-BAYIR, Ayse; Kiziltan, HURİYE ŞENAY; Guler, ERAY METİN; KARAKAS, Ersin; Kocyigit, ABDÜRRAHİM; GÜNEŞ BAYIR, AYŞE; KIZILTAN, HURİYE ŞENAY; GÜLER, ERAY METİN; KOÇYİĞİT, ABDÜRRAHİMPublication Metadata only Thermal and Biochemical Effects of Low Level Electromagnetic Radiation on Rat Brains and Bodies(2014-06-01) KIZILTAN, HURİYE ŞENAY; ERİŞ, ALİ HİKMET; MAYADAĞLI, ALPASLAN; GÜNEŞ BAYIR, AYŞE; YAGCI, B; TAŞPINAR, ÖZGÜR; AYDIN, TEOMAN; TRABZON, M; KIZILTAN, HURİYE ŞENAY; ERİŞ, ALİ HİKMET; MAYADAĞLI, ALPASLAN; GÜNEŞ BAYIR, AYŞE; AYDIN, TEOMANPublication Metadata only Effects of simultaneous integrated boost radiotherapy on kaposi’s sarcoma(2017-12-01) KIZILTAN, HURİYE ŞENAY; ÇOBAN, GANİME; KIRSEVER, ESRA; ERİŞ, ALİ HİKMET; ÖZSÜTÇÜ, NAZMİYE; MAYADAGLı, ALPASLAN; KIZILTAN, HURİYE ŞENAY; ÇOBAN, GANİME; ERİŞ, ALİ HİKMET; MAYADAĞLI, ALPASLANPublication Metadata only Palliative Bioresonance Therapy for metastatic cancer patients Metastatik kanser hastalarında palyatif biyorezonans tedavisi(2018-02-01) KIRSEVER, ESRA; KIZILTAN, HURİYE ŞENAY; YILMAZ, RABİYE; BAYIR, AYŞE GÜNEŞ; BAŞIBÜYÜK, MERYEM; ERİŞ, ALİ HİKMET; ÇAKIR, FATMA BETÜL; GÜL, KÜRŞAT; ŞİMŞEK, MUHARREM; KIZILTEPE, AYŞE; GÜMÜŞ, ASLI; KALAYCI, KÜBRA; AKÇAKAYA, ADEM; AYDIN, TEOMAN; AYDOĞDU, İBRAHİM; SÜT, PELİN ALTINOK; MAYADAĞLI, ALPASLAN; KIZILTAN, HURİYE ŞENAY; BAŞIBÜYÜK, MERYEM; ERİŞ, ALİ HİKMET; ÇAKIR, FATMA BETÜL; GÜL, KÜRŞAT; GÜMÜŞ, ASLI; KALAYCI, KÜBRA; AKÇAKAYA, ADEM; AYDIN, TEOMAN; AYDOĞDU, İBRAHİM; MAYADAĞLI, ALPASLANPublication Metadata only Low dose radiotherapy after the sonodynamic and photodynamic therapy with spirulina for relapsed cancer treatment: With literature review and three case reports(2018-08-01) KIZILTAN, HURİYE ŞENAY; ERIS, ALİ HİKMET; TEKÇE, ERTUĞRUL; AYDIN, TEOMAN; KABLAN, ÖZGÜR; MAYADAĞLI, ALPASLAN; KIZILTAN, HURİYE ŞENAY; ERİŞ, ALİ HİKMET; TEKÇE, ERTUĞRUL; AYDIN, TEOMAN; KABLAN, ÖZGÜR; MAYADAĞLI, ALPASLANPublication Metadata only Short Term Biochemical Effects of 900MHz Cell Phones on Rat Brains and Bodies(2014-02-01) eriş, ali hikmet; kızıltan, huriye şenay; GENÇ, habibe; AYDIN, TEOMAN; TRABZON, metin; SEYİTHANOĞLU, MEHMET HAKAN; ÖZSÜTÇÜ, mustafa; YAĞCI, bülent; UYSAL, ÖMER; ERİŞ, ALİ HİKMET; KIZILTAN, HURİYE ŞENAY; AYDIN, TEOMAN; SEYİTHANOĞLU, MEHMET HAKAN; UYSAL, ÖMERPublication Metadata only Pain management with Radiotherapy and ozone with high dose vitamin C therapy in a case of bone metastatis of breast cancer patient(2018-02-01) KIRSEVER, ESRA; KIZILTAN, HURİYE ŞENAY; YILMAZ, RABİYE; GÜNEŞ BAYIR, AYŞE; BAŞIBÜYÜK, MERYEM; ÇAKIR, FATMA BETÜL; GÜL, KÜRŞAT; ŞİMŞEK, MUHARREM; KIZILTEPE, AYŞE; GÜMÜŞ, ASLI; KALAYCI, KÜBRA; AKÇAKAYA, ADEM; MAYADAĞLI, ALPASLAN; AYDOĞDU, İBRAHİM; ALTINOK SÜT, PELİN; AYDIN, TEOMAN; KIZILTAN, HURİYE ŞENAY; ERİŞ, ALİ HİKMET; GÜNEŞ BAYIR, AYŞE; BAŞIBÜYÜK, MERYEM; ÇAKIR, FATMA BETÜL; GÜL, KÜRŞAT; GÜMÜŞ, ASLI; KALAYCI, KÜBRA; AKÇAKAYA, ADEM; MAYADAĞLI, ALPASLAN; AYDOĞDU, İBRAHİM; ALTINOK SÜT, PELİN; AYDIN, TEOMANPublication Open Access Outcome of Daily Cisplatin with Thoracic Chemoradiotherapy in Advanced Non-small Cell Lung Cancer Patients with Comorbid Disorders: a Pilot Study(2014-01-01) Kiziltan, HURİYE ŞENAY; Bayir, Ayse Gunes; TAŞTEKİN, Didem; Coban, GANİME; Eris, ALİ HİKMET; Aydin, TEOMAN; MAYADAGLI, Alparslan; KIZILTAN, HURİYE ŞENAY; GÜNEŞ BAYIR, AYŞE; ÇOBAN, GANİME; ERİŞ, ALİ HİKMET; AYDIN, TEOMAN; MAYADAĞLI, ALPASLANBackground: Lung cancer is the most common cancer in males worldwide. The principal mode of treatment in the early stage of non-small cell lung cancer (NSCLC) is surgery. However, five-year survival is only about 15% for all stages. The aim is to investigate the effect of daily low dose cisplatin concurrently with radiation therapy in advanced NSCLC patients with poor performance status. Materials and Methods: Ten patients diagnosed as inoperable Stage IIIB NSCLC with comorbid disease were assessed retrospectively in Bezmialem Vakif University, Faculty of Medicine, Department of Radiation Oncology, between 2011 to 2013. ECOG performance status was between 3 and 4. Cisplatin was administered at 6mg/m2 daily, for 5 days a week concurrently with radiotherapy using 160-200 cGy daily fractions, 54 Gy being the lowest and 63 Gy being the highest dose. Results: Complete response at the primary tumour site was obtained in 20% patients. Grade I esophagitis was seen 70 percent of patients, and the grade II haematological toxicity rate was 20 %. Median survival time was 7 months. Conclusions: Median survival time was reasonable, despite the patients ECOG performance status of 3-4, which is similar to groups even without comorbid disorders in comparison to other published papers in the literature. Acceptable toxicity, high response rates and quality of life of patients are the other favourable features.